Dr. Sadia Z. Shah

Dr. Sadia Shah is a Consultant Lung Transplant Pulmonologist and Critical Care specialist at Mayo Clinic, Florida, specializing in taking care of patients with end-stage lung disease, Lung Transplant and Larynx-Trachea Transplant. She served as the Medical Director for Larynx-Trachea Transplant Program and Interim Medical Director for the Lung Transplant Program at Mayo Clinic, Arizona.

Dr. Shah is recognized for leading the Project that performed the first simultaneous CABG and bilateral lung transplant in the world at Mayo Clinic and for initiating the Lung Transplant for COVID disease Program.

Dr. Shah completed her Fellowship in Heart-Lung and Lung Transplant from Stanford University. She is Board Certified in Pulmonary and Critical Care Medicine and has specialized in Lung Transplant medicine.

Dr. Shah is Fellow College of Chest Physicians and an MBA from Isenberg School of Management, University of Massachusetts.

Focus areas

Lung Transplant: Specific areas of interest include Lung Transplant acute cellular rejection, Antibody mediated rejection, Bronchiolitis Obliterans, Lung Transplant infection.

Interstitial Lung Disease: Dr. Shah is interested in Pulmonary Fibrosis, Interstitial Lung Disease secondary to connective tissue disease and Hypersensitivity Pneumonitis.

Larynx-Trachea Transplant: Dr. Shah is interested in Vascularized Composite Allo-transplantation and started the first Larynx-Trachea Transplant Program in Mayo Clinic, Arizona.

Dr. Shah is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Pneumonia, and Lung Transplant.

Dr. Shah is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. She is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 1 clinical trial.